Following eyonis® LCS’ FDA 510 (k) clearance announced on February 9, 2026, Median has activated a phased U.S. launch strategy designed for disciplined national expansion. The Company has conducted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results